FLNC was identified as upregulated in iCCA relative to normal liver, suggesting a potential involvement in tumorigenesis and progression; subsequent studies confirmed its overexpression in CCA, associating it with adverse prognosis and modified tumor microenvironment attributes [42]. This evidence concerns the gene PRRT2 and cholangiocarcinoma.